WO2023242777 - FORMULATIONS COMPRISING β-MANNANASE ENZYME AND METHODS THEREOF
National phase entry:
Publication Number
WO/2023/242777
Publication Date
21.12.2023
International Application No.
PCT/IB2023/056164
International Filing Date
14.06.2023
Title **
[English]
FORMULATIONS COMPRISING β-MANNANASE ENZYME AND METHODS THEREOF
[French]
FORMULATIONS COMPRENANT UNE ENZYME BETA-MANNANASE ET MÉTHODES ASSOCIÉES
Applicants **
ELANCO TIERGESUNDHEIT AG
Inventors
VANGROENWEGHE, Frederic
THAS, Olivier
Priority Data
63/353,446
17.06.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2756 | |
| EPO | Filing, Examination, Granting | 20984 | |
| Japan | Filing, Examination, Granting | 2952 | |
| South Korea | Filing, Examination, Granting | 3594 | |
| USA | Filing, Examination, Granting | 10540 |
Total:
40,826
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to formulations comprising a feed composition and a β-mannanase enzyme. Furthermore, methods of administering the formulation to animals such as porcine animals are provided to demonstrate beneficial effects on the animals. The formulations and methods described herein can benefit overall animal wellbeing and future productivity.[French]
La présente invention concerne des formulations comprenant une composition d'alimentation et une enzyme β-mannanase. En outre, l'invention concerne des méthodes d'administration de la formulation à des animaux, notamment des animaux porcins, qui ont des effets bénéfiques sur les animaux. Les formulations et les méthodes selon l'invention présentent des avantages en termes de bien-être d'animal global et de productivité future.